- Product Description Description
- Table of Contents TOC
- List of Table & Figure LOT
- Get Free Sample PDF Sample PDF
Market Size, 2025
$0.56 BnMarket Estimate, 2026
$0.59 BnMarket Forecast, 2034
$0.94 BnCAGR, 2026–2034
5.95%Executive Summary: Europe Glucose Monitoring Device Market
- Market Scope: Comprehensive Europe glucose monitoring device market analysis covering device types, application settings, country-level frameworks, and adoption metrics.
- Market Valuation: Valued at USD 0.56 billion (2025), estimated at USD 0.59 billion (2026), and projected to reach USD 0.94 billion by 2034, registering a CAGR of 5.95% (2026–2034).
- Primary Growth Drivers: Rapidly aging European population, rising prevalence of diabetes, increasing healthcare expenditure, and the high convenience of home-based self-testing. Key market challenges include manufacturing defects, result errors, and competition from advanced Continuous Glucose Monitors (CGM).
Key Market Segment Metrics (2026–2034)
| Category | Leading Segment (2025 Position) | Fastest-Growing Segment |
|---|---|---|
| By Device Type | Self-Monitoring Devices / Glucose Monitoring Strips (historically capturing significant volume and dominant shares) | Continuous Wearable Devices (CGMs) |
| By Application | Home Setting (representing the primary setting for patient convenience and routine self-testing) | Clinics & Diagnostic Centres / Ambulatory Settings |
| By Country | Germany (leading the European glucose monitoring devices market backed by strong healthcare frameworks and senior populations) | UK, France, and Rest of Europe regional markets |
Major Market Players & Market Structure
Market Structure: Highly competitive medical device landscape featuring global diagnostics leaders competing on sensor accuracy, continuous glucose monitoring innovation, user-friendly home testing tools, and expanded distribution networks.
Key Companies: Roche Diagnostics, LifeScan, Bayer HealthCare, Abbott Diabetes Care Inc., AgaMatrix Inc., Arkray Inc., Medtronic, DexCom Inc., Nova Biomedical Corporation, and Terumo Europe NV.
Europe Glucose Monitoring Device Market Size
The Europe glucose monitoring device market size was valued at USD 0.56 billion in 2025 and is anticipated to reach USD 0.59 billion in 2026 from USD 0.94 billion by 2034, growing at a CAGR of 5.95% during the forecast period from 2026 to 2034.
Europe is the 2nd largest market for glucose monitoring devices globally, which can be linked to the rapidly aging population in this region. Germany is leading the European Glucose Monitoring Devices market.
Blood glucose levels can be tested through glucose monitoring devices of several kinds, including glucose meter, testing strips, and lancets. The device offers the facility of self-testing by using a single glucose meter and different strips. These devices consume less time, as compared to glucose testing by customary methods in laboratories.
The devices allow the test to be performed by the patient as per their convenience at their home, making them popular. It offers the services of monitoring glucose levels in our blood as it tests quantitatively. The market is dominated by the glucose monitoring strip devices with xx% share in 2023 and has the highest growth rate.
The increase in the number of diabetes patients is one of the key drivers supporting the growth of the global SMBG devices market. Also, the healthcare expenditure is increasing, which is the direct cause for the increase in the growth of the market of self-monitoring blood glucose devices. However, this market faces certain losses due to some manufacturing defect or error in results. Also, the accessibility of Continuous Glucose Monitors (CGM) hinders the growth of the market.
Regionally, continuous glucose monitoring results help patients regulate their food intake, exercise, and medications. The device contains sensors for checking the glucose levels from the interstitial fluid. The sensor has a time span where it can be used in one place and then needs to be replaced. This device monitors the glucose levels over time, allowing the patients to identify low and high sugar levels, which are more dangerous. For the self-monitoring devices, people have to test, and it monitors the level at that particular time and not before that.
KEY MARKET PLAYERS
Key market players in the European Glucose Monitoring Device Market include
- Roche Diagnostics
- LifeScan
- Bayer HealthCare
- Abbott Diabetes Care Inc.
- AgaMatrix Inc.
- Arkray Inc.
- Medtronic
- DexCom Inc.
- Nova Biomedical Corporation
- Terumo Europe NV
MARKET SEGMENTATION
This research report on the European glucose monitoring device market has been segmented and sub-segmented into the following categories.
By Device Type
- Continuous Wearable Devices
- Self-Monitoring Devices
By Application
- Hospitals
- Clinics & Diagnostic Centres
- Home Setting
- Ambulatory Settings
By Country
- UK
- France
- Spain
- Germany
- Italy
- Russia
- Sweden
- Denmark
- Switzerland
- Netherlands
- Turkey
- Czech Republic
- Rest of Europe